Not logged in Physician Specialty Differences in Unprofessional Behaviors Observed and Reported by Coworkers Cooper, William O.; Hickson, Gerald B.; Dmochowski, Roger R.; Domenico, Henry J.; Barr, Frederick E.; Emory, Cynthia L.; Gilbert, Jill; Hartman, Gary E.; Lozon, Marie M.; Martinez, William; Noland, Janesta; Webber, Steven A. Share Save
Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma Cardin, Dana B.; Gilbert, Jill; Whisenant, Jennifer G.; Ayers, Gregory D.; Jalikis, Florencia; Dahlman, Kimberly B.; O'Neal, Jamye F.; Revetta, Frank; Shi, Chanjuan; Berlin, Jordan Share Save
Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma Sheth, Siddharth; Gilbert, Jill; Deal, Allison Mary; Chera, Bhishamjit; Murphy, Barbara; Woods, Justin; Miller, Kelsey; Weissler, Mark; Hackman, Trevor; Liao, Jay Justin; Olson, Juneko Grilley; Hayes, David Neil; Weiss, Jared Share Save
Share Save
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer Chiang, Anne C.; Sequist, Lecia Van Dam; Gilbert, Jill; Conkling, Paul; Thompson, Dana; Marcoux, J. Paul; Gettinger, Scott; Kowanetz, Marcin; Molinero, Luciana; O'Hear, Carol; Fasso, Marcella; Lam, Sivuonthanh; Gordon, Michael S. Share Save
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer Mehnert, Janice M.; Varga, Andrea; Brose, Marcia S.; Aggarwal, Rahul R.; Lin, Chia-Chi; Prawira, Amy; de Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A.; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D.; Keam, Bhumsuk Share Save
Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition Gallant, Jean-Nicolas; Sewell, Andrew; Almodovar, Karinna; Wang, Qingguo; Dahlman, Kimberly B.; Abramson, Richard G.; Kapp, Meghan E.; Brown, Brandee T.; Boyd, Kelli L.; Gilbert, Jill; Cohen, Daniel N.; Yarbrough, Wendell G.; Zhao, Zhongming; Lovly, Christine M. Share Save
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy Zandberg, Dan P.; Algazi, Alain P.; Jimeno, Antonio; Good, James S.; Fayette, Jerome; Bouganim, Nathaniel; Ready, Neal E.; Clement, Paul M.; Even, Caroline; Jang, Raymond W.; Wong, Stuart; Keilholz, Ulrich; Gilbert, Jill; Fenton, Moon; Brana, Irene; Henry, Stephanie; Remenar, Eva; Papai, Zsuzsanna; Siu, Lillian L.; Jarkowski, Anthony; Armstrong, Jon M.; Asubonteng, Kobby; Fan, Jean; Melillo, Giovanni; Mesia, Ricard Share Save
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck Weiss, Jared; Gilbert, Jill; Deal, Allison Mary; Weissler, Mark; Hilliard, Chris; Chera, Bhishamjit; Murphy, Barbara; Hackman, Trevor; Liao, Jay Justin; Olson, Juneko Grilley; Hayes, David Neil Share Save
NCCN Guidelines® Insights Head and Neck Cancers, Version 1.2018 Featured Updates to the NCCN Guidelines Colevas, A. Dimitrios; Yom, Sue S.; Pfister, David G.; Spencer, Sharon; Adelstein, David; Adkins, Douglas; Brizel, David M.; Burtness, Barbara; Busse, Paul M.; Caudell, Jimmy J.; Cmelak, Anthony J.; Eisele, David W.; Fenton, Moon; Foote, Robert L.; Gilbert, Jill; Gillison, Maura L.; Haddad, Robert I.; Hicks, Wesley L., Jr.; Hitchcock, Ying J.; Jimeno, Antonio; Leizman, Debra; Maghami, Ellie; Mell, Loren K.; Mittal, Bharat B.; Pinto, Harlan A.; Ridge, John A.; Rocco, James; Rodriguez, Cristina P.; Shah, Jatin P.; Weber, Randal S.; Witek, Matthew; Worden, Frank; Zhen, Weining; Burns, Jennifer L.; Darlow, Susan D. Share Save
Share Save
Share Save
NCCN Guidelines® Insights Head and Neck Cancers, Version 2.2017 Adelstein, David; Gillison, Maura L.; Pfister, David G.; Spencer, Sharon; Adkins, Douglas; Brizel, David M.; Burtness, Barbara; Busse, Paul M.; Caudell, Jimmy J.; Cmelak, Anthony J.; Colevas, A. Dimitrios; Eisele, David W.; Fenton, Moon; Foote, Robert L.; Gilbert, Jill; Haddad, Robert I.; Hicks, Wesley L., Jr.; Hitchcock, Ying J.; Jimeno, Antonio; Leizman, Debra; Lydiatt, William M.; Maghami, Ellie; Mell, Loren K.; Mittal, Bharat B.; Pinto, Harlan A.; Ridge, John A.; Rocco, James; Rodriguez, Cristina P.; Shah, Jatin P.; Weber, Randal S.; Witek, Matthew; Worden, Frank; Yom, Sue S.; Zhen, Weining; Burns, Jennifer L.; Darlow, Susan D. Share Save
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers Goff, Laura W.; Cardin, Dana B.; Whisenant, Jennifer G.; Du, Liping; Koyama, Tatsuki; Dahlman, Kimberly B.; Salaria, Safia N.; Young, Ruth T.; Ciombor, Kristen K.; Gilbert, Jill; Smith, Stephen James; Chan, Emily; Berlin, Jordan Share Save
Share Save
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma Chung, Christine H.; Rudek, Michelle A.; Kang, Hyunseok; Marur, Shanthi; John, Pritish; Tsottles, Nancy; Bonerigo, Sarah; Veasey, Andy; Kiess, Ana; Quon, Harry; Cmelak, Anthony; Murphy, Barbara A.; Gilbert, Jill Share Save
Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN) Munster, Pamela; Elkabets, Moshe; Gilbert, Jill; Razak, Albiruni R. Abdul; Ahn, Myung-Ju; Yen, Chia-Jui; Lee, Se-Hoon; Wang, Hung-Ming; van Herpen, Carla; Lim, Wan-Teck; Demanse, David; Pal, Rupam Ranjan; Huang, Alan; Sheng, Qing; Lambertini, Chiara; Peters, Malte; Coughlin, Christina; Scaltriti, Maurizio; Baselga, Jose; Blumenschein, George Share Save
Head and Neck Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines Pfister, David G.; Spencer, Sharon; Brizel, David M.; Burtness, Barbara; Busse, Paul M.; Caudell, Jimmy J.; Cmelak, Anthony J.; Colevas, A. Dimitrios; Dunphy, Frank; Eisele, David W.; Foote, Robert L.; Gilbert, Jill; Gillison, Maura L.; Haddad, Robert I.; Haughey, Bruce H.; Hicks, Wesley L., Jr.; Hitchcock, Ying J.; Jimeno, Antonio; Kies, Merrill S.; Lydiatt, William M.; Maghami, Ellie; McCaffrey, Thomas; Mell, Loren K.; Mittal, Bharat B.; Pinto, Harlan A.; Ridge, John A.; Rodriguez, Cristina R.; Samant, Sandeep; Shah, Jatin R.; Weber, Randal S.; Wolf, Gregory T.; Worden, Frank; Yom, Sue S.; McMillian, Nicole; Hughes, Miranda Share Save
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma Gilbert, Jill; Schell, Michael J.; Zhao, Xiuhua; Murphy, Barbara; Tanvetyanon, Tawee; Leon, Marino E.; Hayes, D. Neil; Haigentz, Missak, Jr.; Saba, Nabil; Nieva, Jorge; Bishop, Justin; Sidransky, David; Ravi, Rajani; Bedi, Atul; Chung, Christine H. Share Save
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma Galloway, Thomas J.; Wirth, Lori J.; Colevas, Alexander D.; Gilbert, Jill; Bauman, Julie E.; Saba, Nabil F.; Raben, David; Mehra, Ranee; Ma, Anna W.; Atoyan, Ruzanna; Wang, Jing; Burtness, Barbara; Jimeno, Antonio Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}